Biodesix ($BDSX) Insider Trading & Smart Money Activity

Biodesix, Inc. · Diagnostics & Research · Latest filing Jun 25, 2026

Biodesix, Inc. ($BDSX) has 4 analyst ratings on file.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

4

BDSX insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All BDSX insider, congress, 13F and analyst activity

All Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 25, 2026	Analyst	Roth Capital	Reiterates to buy		PT $32		+9.7%	+10.9%			Read
Jun 18, 2026	Analyst	Canaccord Genuity	Reiterates to buy		PT $27		+19.2%	+17.8%			Read
Jun 15, 2026	Analyst	HC Wainwright	Reiterates to buy		PT $26		+11.2%	+34.6%			Read
Jun 15, 2026	Analyst	HC Wainwright	Reiterates to buy		PT $26		+11.2%	+34.6%			Read

1W / 1M / 6M = how BDSX moved from the trade or filing date.

Analyst ratings on BDSX

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 25, 2026	Roth Capital	Reiterates	buy	$32	+9.7%	+10.9%		Read
Jun 18, 2026	Canaccord Genuity	Reiterates	buy	$27	+19.2%	+17.8%		Read
Jun 15, 2026	HC Wainwright	Reiterates	buy	$26	+11.2%	+34.6%		Read
Jun 15, 2026	HC Wainwright	Reiterates	buy	$26	+11.2%	+34.6%		Read

Other diagnostics & research stocks

• $MYGN
• $XGN
• $FLGT
• $NOTV
• $CSTL
• $OPK
• $PSNL
• $NEO

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.